Mohammad Kabir

Mohammad Kabir is a seasoned scientist with extensive experience in drug discovery and antibody development. Currently serving at ChemPartner since May 2021, Mohammad focuses on contract research and antibody discovery utilizing the Berkeley Lights Beacon B cell cloning platform. Previous roles include work at Abcam, where expertise in customized monoclonal antibody production and various assays was developed, and at Tulane University, where Mohammad generated novel cell ablation models for immune cell functionality studies. Academic training includes a Ph.D. in Pharmaceutical Sciences from Niigata University, along with multiple postdoctoral positions, highlighting skills in molecular cloning, protein expression, and immunotherapeutic applications.